What Cyteir Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Leonard Braden Michael | 10% owner | Mar 20 | Open-market buy · P | +170,589 | $2.95 | +$503K | 3,654,053 |
| Leonard Braden Michael | 10% owner | Mar 18 | Open-market buy · P | +113,777 | $3.01 | +$342K | 3,483,464 |
| Renschler Markus Md | President and CEO | Mar 04 | Exercise / conversion · M | +6,304 | $1.69 | +$10.7K | 1,103,661 |
| Gaiero David G | Chief Financial Officer | Mar 04 | Exercise / conversion · M | +2,373 | $1.69 | +$4.01K | 102,391 |
| Renschler Markus Md | President and CEO | Feb 29 | Exercise / conversion · M | +2,537 | $1.20 | +$3.04K | 1,097,357 |
| Renschler Markus Md | President and CEO | Feb 29 | Exercise / conversion · M | +12,607 | $1.69 | +$21.3K | 1,094,820 |
| Gaiero David G | Chief Financial Officer | Feb 29 | Exercise / conversion · M | +4,746 | $1.69 | +$8.02K | 100,018 |
| Gaiero David G | Chief Financial Officer | Feb 29 | Exercise / conversion · M | +3,239 | $1.68 | +$5.44K | 95,272 |
| George Jean | Director | Feb 14 | Exercise / conversion · M | +14,150 | $1.69 | +$23.9K | 14,150 |
| Sands Stephen H. | Director | Feb 09 | Exercise / conversion · M | +12,129 | $1.69 | +$20.5K | 12,129 |
| Thero John F | Director | Feb 08 | Exercise / conversion · M | +12,828 | $1.69 | +$21.7K | 22,828 |
| Zakrzewski Joseph S | Director | Feb 06 | Exercise / conversion · M | +14,150 | $1.69 | +$23.9K | 227,439 |
| Gaiero David G | Chief Financial Officer | Dec 11 | Exercise / conversion · M | +2,373 | $1.69 | +$4.01K | 92,033 |
| Gaiero David G | Chief Financial Officer | Dec 11 | Exercise / conversion · M | +1,620 | $1.68 | +$2.72K | 89,660 |
| Renschler Markus Md | President and CEO | Nov 20 | Exercise / conversion · M | +2,536 | $1.20 | +$3.04K | 1,082,213 |
| Renschler Markus Md | President and CEO | Nov 20 | Exercise / conversion · M | +6,304 | $1.69 | +$10.7K | 1,079,677 |
| Renschler Markus Md | President and CEO | Nov 20 | Exercise / conversion · M | +27,900 | $1.20 | +$33.5K | 1,073,373 |
| Renschler Markus Md | President and CEO | Nov 20 | Exercise / conversion · M | +56,737 | $1.69 | +$95.9K | 1,045,473 |
| Gaiero David G | Chief Financial Officer | Nov 20 | Exercise / conversion · M | +21,356 | $1.69 | +$36.1K | 88,040 |
| Gaiero David G | Chief Financial Officer | Nov 20 | Exercise / conversion · M | +52,584 | $1.68 | +$88.3K | 66,684 |
Loading...